Text Size
163 studies found for:    panitumumab

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Study to Evaluate AMG 706 With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Subjects With Advanced Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer
Interventions: Biological: Panitumumab;   Drug: AMG 706
2 Recruiting Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Panitumumab
3 Active, not recruiting Panitumumab Combination Study With AMG 102 or AMG 479 in Wild-type KRAS mCRC
Conditions: Colon Cancer;   Colorectal Cancer;   Gastrointestinal Cancer;   Metastatic Colorectal Cancer;   Rectal Cancer
Interventions: Drug: Panitumumab + AMG 102;   Drug: Panitumumab + AMG 479;   Drug: AMG 479;   Drug: AMG 102;   Drug: Panitumumab
4 Terminated Radio-chemotherapy With or Without Panitumumab (Vectibix®) in Irresectable Squamous Cell Carcinoma or Adenocarcinoma of the Oesophagus
Condition: Irresectable Squamous Cell or Adenocarcinoma of the Oesophagus
Interventions: Drug: CRT + Panitumumab;   Drug: Concurrent chemoradiation therapy without panitumumab
5 Active, not recruiting Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Panitumumab;   Drug: Carboplatin;   Drug: Gemcitabine
6 Unknown † Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)
Condition: Carcinoma, Squamous Cell
Intervention: Drug: infusions of Panitumumab
7 Active, not recruiting Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer and Liver-only Metastases
Condition: Colorectal Cancer
Interventions: Drug: Panitumumab+FOLFOX-4;   Drug: Panitumumab+FOLFIRI
8 Recruiting ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Subjects With KRAS Wild-Type Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Cetuximab (Erbitux);   Drug: Panitumumab (Vectibix)
9 Completed New Individualized Therapy Trial for Metastatic Colorectal Cancer
Conditions: Colorectal Neoplasm;   Colorectal Cancer
Interventions: Drug: Imatinib mesylate followed by a combination of imatinib mesylate & panitumumab;   Drug: Standard-of-care treatment with panitumumab
10 Recruiting Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Drug: Panitumumab
11 Completed
Has Results 		PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study
Condition: Colorectal Cancer
Interventions: Drug: Oxaliplatin Based Chemotherapy;   Drug: Panitumumab;   Drug: Irinotecan Based Chemotherapy;   Drug: Bevacizumab
12 Terminated Panitumumab and Irinotecan for Malignant Gliomas
Condition: Malignant Glioma of Brain
Intervention: Drug: Panitumumab in Combination with Irinotecan
13 Recruiting Panitumumab Pediatric Study
Condition: Solid Tumors
Intervention: Drug: Panitumumab Treatment
14 Recruiting Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type KRAS Who Have Resected Hepatic Metastases From Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: panitumumab;   Drug: Randomization to No Panitumumab
15 Completed Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors
Conditions: Tumors;   Oncology;   Solid Tumors
Interventions: Drug: panitumumab (ABX-EGF);   Drug: Panitumumab
16 Recruiting PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)
Condition: Cholangiocarcinomas
Interventions: Drug: Cisplatin, Gemcitabine, Panitumumab;   Drug: Cisplatin, Gemcitabine
17 Completed
Has Results 		Evaluating ABX-EGF is the Same as "Panitumumab" in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Irinotecan;   Drug: ABX-EGF is the same as "Panitumumab";   Drug: 5-Fluorouracil;   Drug: Leucovorin
18 Completed Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer
Conditions: Rectal Cancer;   Colon Cancer
Interventions: Drug: FOLFOX-4;   Drug: AMG 706;   Biological: Panitumumab (Part 1a only);   Drug: FOLFIRI
19 Recruiting Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Panitumumab;   Drug: Cisplatin;   Radiation: Radiation Therapy
20 Recruiting Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Other: Best Supportive Care;   Drug: Panitumumab
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years